A South Korean Biotech Firms Gets $183.3M Funding to Build Bitcoin Treasury
-
币界网报道：South Korean biotech firm Bridge Biotherapeutics (288330) is shifting to a bitcoin treasury strategy with a $183.3 million investment from crypto firm Parataxis, rebranding as Parataxis Korea while remaining listed on KOSDAQ. Parataxis partner Andrew Kim cited growing institutional interest in BTC treasury models, following U.S.-based MicroStrategy and Japan's Metaplanet, which hold 2.8% of all bitcoin and 10,000 BTC ($1.04B) respectively. Bridge's shares surged 20.5% to 943 won ($0.69) on the announcement, joining healthcare firms Semler Scientific and Prenetics Global in adopting bitcoin reserves. Parataxis is preparing for a U.S. SPAC merger with SilverBox Corp IV (SBXD).
下一篇
Yi Lihua responded to the high-control NEIRO: I only bought and did not sell in the secondary market, it was purely a bottom-fis
- According to Yu Jin's analysis, Trend Research under LD Capital not only holds 173,000 ETH...
208441